Abdom Radiol (NY)

1. ZHANG X, Wang Y, Xu X, Zhang J, et al
   Bladder MRI with deep learning-based reconstruction: a prospective evaluation of muscle invasiveness using VI-RADS.
   Abdom Radiol (NY). 2024;49:1615-1625.
   

   >> Share

   
   

   
   Adv Rheumatol

2. SOUZA AWS, Dantas JG, Montandon ACOES, Calich AL, et al
   Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment.
   Adv Rheumatol. 2024;64:41.
   

   >> Share

   
   

   
   Aging (Albany NY)

3. MAO X, Chen X, Xu Z, Ding L, et al
   The identification of a N(6)-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma.
   Aging (Albany NY). 2024;16:7774-7798.
   

   >> Share

   
   

   
   Am Soc Clin Oncol Educ Book

4. HEMENWAY G, Anker JF, Riviere P, Rose BS, et al
   Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient.
   Am Soc Clin Oncol Educ Book. 2024;44:e432054.
   

   >> Share

   
   

   
   Asian J Surg

5. LOU K, Chi J, Zheng X, Cui Y, et al
   PPP1R14A as a potential biomarker for predicting the progression and prognosis of bladder cancer.
   Asian J Surg. 2024 May 18:S1015-9584(24)00966.
   

   >> Share

   
   

   
   Biomarkers

6. LU C, Lin S, Wen Z, Sun C, et al
   Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
   Biomarkers. 2024 May 20:1-21. doi: 10.1080/1354750X.2024.2358312.
   

   >> Share

   
   

   
   BJU Int

7. FINOCCHIARO A, Paciotti M, Contieri R, Fasulo V, et al
   Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?
   BJU Int. 2024 May 22. doi: 10.1111/bju.16406.
   

   >> Share

   
   

   
   BMC Urol

8. ALFARIZI ZY, Subekti E, Danarto, Yuri P, et al
   A rare case of spontaneous bladder wall abscess mimicking bladder tumour in young women.
   BMC Urol. 2024;24:109.
   

   >> Share

   
   
9. WANG XL, Wang YX, Chen JZ, Liu XY, et al
   Clinical characteristics and molecular mechanisms underlying bladder cancer in individuals with spinal cord injury: a systematic review.
   BMC Urol. 2024;24:111.
   

   >> Share

   
   

   
   Cancer Cell Int

10. ZHANG C, Wang Y, Guo X, Wang Z, et al
    SLC7A5 correlated with malignancies and immunotherapy response in bladder cancer.
    Cancer Cell Int. 2024;24:182.
    

    >> Share

    
    

    
    Cancer Lett

11. YU Y, Liang Y, Xie F, Zhang Z, et al
    Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation.
    Cancer Lett. 2024 May 16:216964. doi: 10.1016/j.canlet.2024.216964.
    

    >> Share

    
    

    
    Clin Genitourin Cancer

12. KOEHNE EL, Bakaloudi DR, Ghali F, Nyame Y, et al
    Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer.
    Clin Genitourin Cancer. 2024 Apr 25:102100. doi: 10.1016/j.clgc.2024.102100.
    

    >> Share

    
    

    
    Clin Nutr

13. LIU Z, Teng C, Wan W, Wu F, et al
    A panel of four plasma amino acids is a promising biomarker for newly diagnosed bladder cancer.
    Clin Nutr. 2024;43:1599-1608.
    

    >> Share

    
    

    
    Clin Transl Oncol

14. CLIMENT MA, Alvarez C, Morales R, Maroto P, et al
    Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.
    Clin Transl Oncol. 2024;26:1532-1538.
    

    >> Share

    
    

    
    Curr Oncol

15. ANTAR RM, Xu VE, Adesanya O, Drouaud A, et al
    Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer.
    Curr Oncol. 2024;31:2566-2581.
    

    >> Share

    
    

    
    Eur J Surg Oncol

16. SIECH C, Baudo A, de Angelis M, Jannello LMI, et al
    Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement.
    Eur J Surg Oncol. 2024;50:108297.
    

    >> Share

    
    

    
    Eur Urol Oncol

17. WU Z, Zhao G, Zhang Z, Shen C, et al
    Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 May 17:S2588-9311(24)00110.
    

    >> Share

    
    

    
    Histol Histopathol

18. STROPE AM, Phillips C, Khadgi S, Jenkinson SA, et al
    Differential expression of WNT5A long and short isoforms in non-muscle-invasive bladder urothelial carcinoma.
    Histol Histopathol. 2024;39:715-727.
    

    >> Share

    
    

    
    Immun Ageing

19. ZHAO J, Luo X, Yang C, Yang X, et al
    Chemokine receptor 7 contributes to T- and B-cell filtering in ageing bladder, cystitis and bladder cancer.
    Immun Ageing. 2024;21:33.
    

    >> Share

    
    

    
    Int Braz J Urol

20. FARIA EF, Maciel CVM, Melo PA, Tobias-Machado M, et al
    Mesentery-Sparing Technique: a New Intracorporeal Approach for Urinary Diversion in Robot-Assisted Radical Cystectomy.
    Int Braz J Urol. 2024;50:489-499.
    

    >> Share

    
    

    
    Int J Surg

21. LIU L, Li K, Wang SG, Wang J, et al
    The prognostic impact of tumor location in non-muscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing chinese multicenter and SEER registries.
    Int J Surg. 2024 May 24. doi: 10.1097/JS9.0000000000001675.
    

    >> Share

    
    

    
    Int Urol Nephrol

22. YAN T, Zhou W, Li C
    Discovery of a T cell proliferation-associated regulator signature correlates with prognosis risk and immunotherapy response in bladder cancer.
    Int Urol Nephrol. 2024 May 24. doi: 10.1007/s11255-024-04086.
    

    >> Share

    
    

    
    J Cancer Immunol (Wilmington)

23. RAMAMURTHY C, Wheeler KM, Trecarten S, Hassouneh Z, et al
    Perioperative Immune Checkpoint Blockade for Muscle-Invasive and Metastatic Bladder Cancer.
    J Cancer Immunol (Wilmington). 2024;6:29-39.
    

    >> Share

    
    

    
    J Cancer Res Clin Oncol

24. CHEN Z, Ou Y, Ye F, Li W, et al
    Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer.
    J Cancer Res Clin Oncol. 2024;150:264.
    

    >> Share

    
    

    
    J Cell Mol Med

25. WANG Y, Zhu H, Zhang L, He J, et al
    Common immunological and prognostic features of lung and bladder cancer via smoking-related genes: PRR11 gene as potential immunotherapeutic target.
    J Cell Mol Med. 2024;28:e18384.
    

    >> Share

    
    

    
    J Proteome Res

26. CHANG Q, Chen Y, Yin J, Wang T, et al
    Comprehensive Urinary Proteome Profiling Analysis Identifies Diagnosis and Relapse Surveillance Biomarkers for Bladder Cancer.
    J Proteome Res. 2024 May 24. doi: 10.1021/acs.jproteome.4c00199.
    

    >> Share

    
    

    
    Mol Biotechnol

27. ZENG XX, Wu Y
    Strategies of Bladder Reconstruction after Partial or Radical Cystectomy for Bladder Cancer.
    Mol Biotechnol. 2024 May 18. doi: 10.1007/s12033-024-01163.
    

    >> Share

    
    

    
    Mutat Res

28. WOHLFAHRT J, Verma N, Alsaleh R, Kersch C, et al
    A pilot study exploring time- and dose-dependent DNA damage and chromosomal instability caused by benzo[a]pyrene in two urothelial cell types.
    Mutat Res. 2024;828:111855.
    

    >> Share

    
    

    
    Nat Commun

29. BECKABIR W, Zhou M, Lee JS, Vensko SP, et al
    Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
    Nat Commun. 2024;15:4448.
    

    >> Share

    
    

    
    Nat Rev Urol

30. MATYE D, Leak J, Woolbright BL, Taylor JA 3rd, et al
    Preclinical models of bladder cancer: BBN and beyond.
    Nat Rev Urol. 2024 May 20. doi: 10.1038/s41585-024-00885.
    

    >> Share

    
    

    
    Oxf Med Case Reports

31. GLAVINOV MS, Krsteska B, Stojmenova V, Petrovska T, et al
    Adenoid cystic/basal-cell carcinoma of the prostate following high-grade urothelial bladder cancer: a case report.
    Oxf Med Case Reports. 2024;2024:omae050.
    

    >> Share

    
    

    
    Rev Assoc Med Bras (1992)

32. MURTA CB, Hayek KKRE, Dias BC, Yorioka MAW, et al
    Increased risk of bladder cancer recurrence due to bacillus Calmette-Guerin shortage in Brazil.
    Rev Assoc Med Bras (1992). 2024;70:e20231116.
    

    >> Share

    
    

    
    Surg Oncol

33. MA R, Sheybaee Moghaddam F, Ghoreifi A, Ladi-Seyedian S, et al
    The effect of enhanced recovery after surgery on oncologic outcome following radical cystectomy for urothelial bladder carcinoma.
    Surg Oncol. 2024;54:102061.
    

    >> Share

    
    

    
    Target Oncol

34. UCHIMOTO T, Tsuchida S, Komura K, Fukuokaya W, et al
    Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.
    Target Oncol. 2024;19:401-410.
    

    >> Share

    
    

    
    Urology

35. SEKAR RR, Irani S, Maganty A, Montgomery JS, et al
    Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Urology. 2024 May 17:S0090-4295(24)00359-5. doi: 10.1016/j.urology.2024.
    

    >> Share

    
    

    
    Virchows Arch

36. LOUIS EK, Abdelkawi IF, Refaiy A, Ahmed AM, et al
    N-myc downstream-regulated gene 1 can promote vasculogenic mimicry and angiogenesis in urothelial carcinoma.
    Virchows Arch. 2024;484:827-836.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share